Genetic and antigenic analysis of the first A/New Caledonia/20/99-like H1N1 influenza isolates reported in the Americas.
From February through May of 1999, 13 cases of Influenza A virus (FLUAV), type H1N1 were reported at a Department of Defense influenza surveillance sentinel site in Lima, Peru. Genetic and antigenic analysis by hemagglutination inhibition and direct nucleotide sequencing of the HA1 region of the hemagglutinin gene were performed on two isolates, A/Peru/1641/99 and A/Peru/1798/99. Both isolates were distinct from the Bayern/7/95-like viruses circulating in the Americas and closely related to a Beijing/262/95-like variant, A/New Caledonia/20/99. With the exception of travel-related cases, the detection of these isolates represents the first appearance of New Caledonia/20/99-like viruses in the Americas. Since the characterization of these Peru isolates, a number of New Caledonia/20/99-like viruses have been reported worldwide. For the 2000/01 and 2001/02 influenza seasons, the World Health Organization (WHO) has recommended the inclusion of A/New Caledonia/20/99 as the H1N1 vaccine component for both the southern and northern hemispheres.
Daum
Luke T
LT
Brooks Air Force Base, San Antonio, TX 78235, USA.
Canas
Linda C
LC
Smith
Catherine B
CB
Klimov
Alexander
A
Huff
William
W
Barnes
William
W
Lohman
Kenton L
KL
D000595:Amino Acid Sequence; D000818:Animals; D000956:Antigens, Viral / Q000276:immunology; D005289:Ferrets / Q000276:immunology; D006801:Humans; D007251:Influenza, Human / Q000453:epidemiology* / Q000276:immunology / Q000382:microbiology*; D029521:Alphainfluenzavirus / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification*; D008969:Molecular Sequence Data; D009154:Mutation; D010568:Peru / Q000453:epidemiology; D010802:Phylogeny; D015995:Prevalence; D018571:Sentinel Surveillance
D000956:Antigens, Viral